Sponsor or institution
Clinical trials and research at The Third Affiliated Hospital of Guangzhou Medical University
As of November 12, 2026, Find a Trial lists 7 clinical trials run by The Third Affiliated Hospital of Guangzhou Medical University that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Maternal MT-ND1 Mutation and Male Infertility | — | Guangzhou, Guangdong | Recruiting | Jul 9, 2026 |
| Vision Transformer–based ultrasound AI to detect placenta accreta spectrum | — | Guangzhou, Guangdong | Recruiting | Jun 11, 2026 |
| Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta | — | Guangzhou, Guangdong and 5 other locations | Recruiting | Jun 18, 2025 |
| Monitoring blood markers to predict cervical cancer recurrence after surgery | — | Guangzhou, Guangdong | Recruiting | May 20, 2024 |
| Screening and prevention of gestational hypertension and preeclampsia | — | Guangzhou, Guangdong | Recruiting | Apr 25, 2024 |
| Using Vosevi to treat patients with chronic Hepatitis C who have tried other medications | — | Guangzhou, Guangdong | Recruiting | Dec 22, 2023 |
| Using Tenofovir Alafenamide to Prevent Hepatitis B Transmission from Mother to Child | — | Guangzhou, Guangdong | Recruiting | Jul 20, 2022 |
All recruiting trials (7)
-
Maternal MT-ND1 Mutation and Male Infertility
Researchers look at whether a mitochondrial MT-ND1 variant inherited from mothers is linked to very low or absent sperm production in men with idiopathic infertility.
-
Vision Transformer–based ultrasound AI to detect placenta accreta spectrum
A AI tool uses ultrasound video inputs to help see if the placenta is abnormally attached during pregnancy in women at risk.
-
Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta
We will test whether scheduling cesarean delivery at 37 weeks instead of 36 weeks helps newborns without increasing maternal bleeding in pregnant women with placenta previa and accreta.
-
Monitoring blood markers to predict cervical cancer recurrence after surgery
This study is testing if checking certain blood markers can help predict if cervical cancer will come back after surgery in patients with HPV-positive cervical cancer.
-
Screening and prevention of gestational hypertension and preeclampsia
This study is testing a new way to identify and manage pregnant women at high risk for preeclampsia to help prevent complications for both mothers and babies.
-
Using Vosevi to treat patients with chronic Hepatitis C who have tried other medications
This study is testing if Vosevi can help people with chronic Hepatitis C who haven't had success with other treatments feel better and clear the virus from their system.
-
Using Tenofovir Alafenamide to Prevent Hepatitis B Transmission from Mother to Child
This study is testing if a new medication called Tenofovir Alafenamide can safely help pregnant women with Hepatitis B prevent passing the virus to their babies.
Quick answers
How many clinical trials run by The Third Affiliated Hospital of Guangzhou Medical University are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.